Purchase Order HHSN2612006MQ609843P

This contract was awarded by the National Institutes of Health (NIH) National Cancer Institute to the Cancer Prevention Institute of California, a non-profit organization, to conduct a "Patterns of Care/Quality of Care Study: Diagnosis Year 2016" from July 31, 2017 to July 30, 2018. The contract, which has a firm fixed price of $159,811.00, is a delivery order that is not set aside for any particular business type. The study is part of the Surveillance, Epidemiology and End Results...

This is a delivery order contract awarded by the National Cancer Institute (NCI), part of the Department of Health and Human Services (HHS) National Institutes of Health (NIH), to the Public Health Institute (PHI), a non-profit organization. The contract is for the NCI Patterns of Care (POC)/Quality of Care Study, focusing on diagnosis years 2017 for non-small cell lung cancer (NSCLC) and 2018 for NSCLC and melanoma. The potential value of the contract is $225,471. This delivery order is part of...

This firm fixed-price purchase order was awarded by the National Institutes of Health's National Cancer Institute to Kaiser Foundation Hospitals, doing business as Kaiser Permanente, for a study to assess mammographic breast density and its relationship to the risk of contralateral breast cancer development. The $149,765 contract supports retrieving mammograms from the Kaiser Permanente Washington Health Research Institute cohort of breast cancer survivors to evaluate mammographic breast density...

<p>This is a definitive federal contract awarded by the National Cancer Institute (NCI), a civilian agency, to Mansfield Medical Research on September 15, 1992. The contract has a ceiling value of $443,137,907.91 and is for the PROSTATE, LUNG, COLORECTAL AND OVARIAN CANCER SCREENING TRIAL. The contract is a cost-sharing agreement and does not have a set-aside designation. The contract is scheduled to be completed by March 31, 2012. The place of performance is Marshfield, Wisconsin.</p>

The National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services, has awarded a $88,032 firm fixed price purchase order to Fred Hutchinson Cancer Center, doing business as Seattle Cancer Care Alliance, for aliquoting and shipping serum samples of selected breast cancer cases and controls in the Women's Health Initiative. As the prime contractor, Fred Hutchinson Cancer Center will deliver the requested products and services from...

This is a $97,457 firm-fixed price purchase order awarded by the National Cancer Institute (NCI) to the Department of Public Health Connecticut for the NCI Patterns of Care Study focused on diagnosis year 2020 breast and colorectal cancer cases. The study aims to collect data on biomarker testing, targeted therapies, adjuvant treatments, and the impact of the COVID-19 pandemic on cancer screening, diagnosis, treatment, and supportive/palliative care. It involves a stratified random sample of...

The National Cancer Institute awarded a $1,995,119 firm-fixed-price Phase II SBIR contract to Boston Cell Standards Inc., a for-profit manufacturer of medical devices, diagnostics, and related services. The contract, which is set aside for small businesses, is to develop quantitative traceable reference materials for use in cancer detection and diagnostics. This award builds on a previous $385,889 Phase I SBIR contract with the National Cancer Institute. Boston Cell Standards has also received...

The National Cancer Institute (NCI) awarded a $87,431.00 firm fixed price purchase order to the University of New Mexico (UNM) Health Sciences Center to collect data for the NCI Patterns of Care Study, focusing on breast and colorectal cancer cases diagnosed in 2020. This study aims to describe the use of recommended biomarker tests, targeted therapies, and other adjuvant treatments, as well as document the effects of the COVID-19 pandemic on cancer screening, diagnosis, treatment, and...

This is a firm fixed price delivery order contract awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to the Connecticut Department of Public Health's Business Office Division. The contract is for a &quot;Patterns of Care/Quality of Care Study: Diagnosis Year 2014 (SEER)&quot; with a potential value of $49,084.00 and a completion date of August 14, 2016. The contract supports the Surveillance, Epidemiology, and End Results (SEER)...

The Department of Public Health Connecticut, Business Office Division was awarded a $42,052 firm-fixed price delivery order contract by the National Cancer Institute (NCI) to improve the completeness of treatment and other key data elements by linking 15-month resubmitted data from Commission on Cancer hospitals. This contract is part of the NCI's Surveillance, Epidemiology, and End Results (SEER) Program, which collects and publishes cancer incidence and survival data from population-based...